Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment Naive AML”

12 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 12 results

Early research (Phase 1)Ended earlyNCT02203773
What this trial is testing

Study of ABT-199 (GDC-0199) in Combination With Azacitidine or Decitabine (Chemo Combo) in Subjects With Acute Myelogenous Leukemia (AML)

Who this might be right for
Acute Myelogenous LeukemiaMyelogenous LeukemiaTreatment Naive AML
AbbVie 212
Testing effectiveness (Phase 2)Study completedNCT02287233
What this trial is testing

A Study Evaluating Venetoclax in Combination With Low-Dose Cytarabine in Treatment-Naïve Participants With Acute Myelogenous Leukemia

Who this might be right for
Acute Myelogenous LeukemiaAML
AbbVie 94
Testing effectiveness (Phase 2)UnknownNCT05100303
What this trial is testing

Evaluate the Tolerance and Efficacy of Mitoxantrone Hydrochloride Liposome Injection Combined With Cytarabine in Patients With Acute Myeloid Leukemia (AML)

Who this might be right for
Treatment-naive or Relapsed or Refractory Acute Myeloid Leukemia (AML)
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 58
Testing effectiveness (Phase 2)Ended earlyNCT02770820
What this trial is testing

Laboratory-Treated (Central Memory/Naive) CD8+ T Cells in Treating Patients With Newly Diagnosed or Relapsed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaEBV-Positive Neoplastic Cells PresentHLA-A*0201 Positive Cells Present+2 more
Fred Hutchinson Cancer Center 9
Early research (Phase 1)Study completedNCT01814826
What this trial is testing

Study of MLN4924 Plus Azacitidine in Treatment-naive Participants With Acute Myelogenous Leukemia (AML) Who Are 60 Years or Older

Who this might be right for
Acute Myelogenous Leukemia
Millennium Pharmaceuticals, Inc. 64
Early research (Phase 1)Active Not RecruitingNCT04964505
What this trial is testing

Uproleselan, Azacitidine, and Venetoclax for the Treatment of Treatment Naive Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Brian Jonas 16
Early research (Phase 1)Looking for participantsNCT06514261
What this trial is testing

Testing the Combination of an Anti-Cancer Drug, Iadademstat, With Other Anti-Cancer Drugs (Venetoclax and Azacitidine) for Treating AML

Who this might be right for
Acute Myeloid Leukemia
National Cancer Institute (NCI) 45
Large-scale testing (Phase 3)Study completedNCT03069352
What this trial is testing

Venetoclax in Combination With Low Dose Cytarabine Versus Low Dose Cytarabine Alone in Treatment Naive Patients With Acute Myeloid Leukemia Who Are Ineligible for Intensive Chemotherapy

Who this might be right for
Acute Myeloid Leukemia (AML)
AbbVie 211
Large-scale testing (Phase 3)Not Yet RecruitingNCT06182592
What this trial is testing

A Bridging Study of Liposomal Cytarabine-Daunorubicin in Treating Olderly Patients With Treatment-naive High-Risk (Secondary) Acute Myeloid Leukemia

Who this might be right for
High-risk (Secondary) Acute Myeloid Leukemia
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. 120
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06652685
What this trial is testing

Molecular Subtype Combined with Early Minimal Residual Disease to Optimize the Treatment of Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia (AML)
Ruijin Hospital 218
Large-scale testing (Phase 3)UnknownNCT05264883
What this trial is testing

Venetoclax+HMA+Aclarubicin Versus Venetoclax+HMA in Treatment-Naive Elderly Patients With AML

Who this might be right for
Acute Myeloid Leukemia
The First Affiliated Hospital with Nanjing Medical University 170
Early research (Phase 1)Looking for participantsNCT03113643
What this trial is testing

SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromeBlastic Plasmacytoid Dendritic Cell Neoplasm
Dana-Farber Cancer Institute 72